Teladoc Health, Inc.
TDOC
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $1.2B
$6.50
▲ +2.20%
P/E
-6.57
Mkt Cap
$1.2B
52-Wk Range
$4.40–$9.89
52-Week Range
$4.40 - $9.89
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 14.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Integrated multi-brand platform (Teladoc, Livongo, BetterHelp) serving diverse healthcare needs
- Established relationships with major employers, health plans, and health systems representing millions of members
- Proprietary data analytics and AI-driven insights for personalized chronic disease management
- Regulatory expertise and compliance infrastructure across multiple healthcare verticals
- Scalable technology platform with network effects and switching costs
Bear Case
1 risk
- High volatility (beta 2.1). Larger-than-normal price swings expected.
Growth
Stable outlook
Premium gross margins (70%)
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Weak
-14.6% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying TDOC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 28, 2026
JUL 29, 2026
Reported EPS of -$0.21 vs -$0.25 consensus (+15.9% surprise). Revenue of $606.9M vs $615.4M expected (-1.4%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+15.9%
Revenue trend · last 8Q
—
-3%
-3%
-2%
-2%
+0%
-2%
-4%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$640.5M
$640.5M
$629.4M
$631.9M
$626.4M
$642.3M
$613.8M
$606.9M
Margins · last 8Q
Gross
83.8%
Operating
-8.3%
Profit
-6.4%
Wall Street consensus
6 analysts · 17% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
17%
Hold
83%
Sell
0%
Median Price Target
—
Latest: Jefferies · Jul 30, 2026
vs Industry
How TDOC stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related